| FairsOnline

Columvi Combination Shows Promising Survival Benefit in Aggressive Lymphoma as FDA Review Progresses

Submitted by fairsonline´s … on Tue, 05/27/2025 - 20:33

SHERIDAN, WYOMING – May 27, 2025 – Roche has announced an encouraging update on its supplemental Biologics License Application (sBLA) for Columvi® (glofitamab) in combination with gemcitabine and oxaliplatin (GemOx), following discussion by the FDA’s Oncologic Drugs Advisory Committee (ODAC). The combination therapy demonstrated a significant 41% reduction in the risk of death in patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) who are not candidates for autologous stem cell transplant.

FDA Approves Roche’s VENTANA MET (SP44) RxDx Assay as First Companion Diagnostic for Emrelis Treatment in NSCLC

Submitted by fairsonline´s … on Tue, 05/27/2025 - 20:27

SHERIDAN, WYOMING – May 27, 2025 – Roche has announced FDA approval of its VENTANA® MET (SP44) RxDx Assay, marking a major milestone in companion diagnostics for non-small cell lung cancer (NSCLC). This approval paves the way for a more precise identification of patients eligible for AbbVie’s Emrelis™ (telisotuzumab vedotin-tllv), a targeted therapy for non-squamous NSCLC with MET protein overexpression.

Enhancing Treatment Precision in Lung Cancer Care

Roche’s Perjeta-Based Regimen Shows 17% Reduction in Mortality in HER2-Positive Early Breast Cancer After 10 Years

Submitted by fairsonline´s … on Tue, 05/27/2025 - 20:20

SHERIDAN, WYOMING – May 27, 2025 – Roche has announced compelling final results from the decade-long APHINITY Phase III clinical trial, demonstrating a significant 17% reduction in the risk of death for patients with HER2-positive early-stage breast cancer who received a Perjeta® (pertuzumab)-based adjuvant therapy. These findings reinforce the strategic role of the Perjeta-based regimen in long-term disease management and will be presented as a late-breaking abstract at the 2025 ESMO Breast Cancer Congress.

Roche Launches Elecsys PRO-C3 Test to Advance Precision in Liver Fibrosis Diagnostics

Submitted by fairsonline´s … on Tue, 05/27/2025 - 20:06

SHERIDAN, WYOMING – May 27, 2025 – Roche has introduced its Elecsys® PRO-C3 diagnostic test, marking a major step forward in the assessment of liver fibrosis severity, particularly in patients with metabolic dysfunction–associated steatotic liver disease (MASLD). With the ability to deliver results in just 18 minutes, the new test is poised to streamline diagnostics and enable earlier, more accurate clinical decision-making.

Strategic Response to a Global Health Burden

ANGA COM 2025 Poised to Set New Benchmarks for Broadband and Media Innovation

Submitted by J. Mikhail on Tue, 05/27/2025 - 04:24

SHERIDAN, WYOMING – May 27, 2025 – ANGA COM, Europe’s premier business platform for broadband, television, and online media, is set to return from June 3 to 5, 2025, in Cologne, Germany, with a bold agenda designed to shape the future of digital infrastructure and content delivery across Europe and beyond.

Hettich Unveils Next-Generation Digital Assembly Tools at interzum 2025

Submitted by fairsonline´s … on Tue, 05/27/2025 - 03:48

SHERIDAN, WYOMING – May 27, 2025 – Hettich is redefining the digital landscape of furniture manufacturing with the introduction of intuitive assembly technologies showcased at interzum 2025. The fittings specialist is highlighting its latest advancements in user-friendly digital tools—from augmented reality and QR code guidance to a debut 3D printing portal—designed to streamline operations and enhance productivity across workshops and production facilities.

Empowering Workflows Through Digital Innovation

Hettich’s SpinLines Redefine Space Efficiency with Transformative Swivel Technology

Submitted by fairsonline´s … on Tue, 05/27/2025 - 03:42

SHERIDAN, WYOMING – May 27, 2025 – Hettich is reshaping the future of space utilization with its award-winning SpinLines product family—a transformative suite of turning swivel systems designed to revolutionize how furniture and interiors function. Debuted in phases since 2019 and spotlighted at interzum 2023 and 2025, these innovative solutions enable unprecedented flexibility in residential and commercial design, offering new avenues for architects, fabricators, and furniture manufacturers.

Revolutionizing Workspace Design: Hettich Unveils RoomSpin and SpinLines at interzum 2025

Submitted by fairsonline´s … on Tue, 05/27/2025 - 03:28

SHERIDAN, WYOMING – May 27, 2025 – Hettich is reshaping the future of workspace design with its latest innovations unveiled at interzum 2025. Under the theme “Transforming Spaces – with innovative motion,” the company presents RoomSpin and SpinLines—modular systems that bring motion, flexibility, and architectural intelligence to contract furnishing.

Hettich Sets Strategic Innovation Agenda at interzum 2025 with New Fittings Portfolio

Submitted by fairsonline´s … on Tue, 05/27/2025 - 03:24

SHERIDAN, WYOMING – May 27, 2025 – Hettich is reaffirming its role as a global innovation leader in furniture fittings at interzum 2025, unveiling a strategically aligned portfolio that meets the evolving demands of trade professionals, furniture retailers, and manufacturers. The new offerings reflect a forward-looking vision centered on user convenience, functional performance, and market adaptability—spanning living, kitchen, workspace, and outdoor applications.

Transforming Furniture Innovation: Hettich Unveils Strategic Product Advancements at interzum 2025

Submitted by fairsonline´s … on Tue, 05/27/2025 - 03:15

SHERIDAN, WYOMING – May 27, 2025 – Hettich, one of the world’s leading manufacturers of furniture fittings, is poised to reshape the future of interiors with its cutting-edge innovations and sustainability-driven initiatives showcased at interzum 2025. Under the visionary theme “Transforming Spaces – with innovative motion,” the company brings forward a portfolio that highlights its commitment to customer-centric design, strategic industry collaboration, and environmentally responsible business practices.

Subscribe to